Overview of Cardiac Arrhythmias and Treatment Strategies
Pharmaceuticals · 06.06.2023 · 16 (6) · 844
DOI: 10.3390/ph16060844 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 06.06.2023. Verfasst von John Kingma und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Ferdinand Vandry Pavillon, 1050 Av. de la Médecine, Québec City, QC G1V 0A6, Canada. Die Arbeit wurde bisher 65-mal zitiert (Crossref) und nennt 193 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Maintenance of normal cardiac rhythm requires coordinated activity of ion channels and transporters that allow well-ordered propagation of electrical impulses across the myocardium. Disruptions in this orderly process provoke cardiac arrhythmias that may be lethal in some patients. Risk of common acquired arrhythmias is increased markedly when structural heart disease caused by myocardial infarction (due to fibrotic scar formation) or left ventricular dysfunction is present. Genetic polymorphisms influence structure or excitability of the myocardial substrate, which increases vulnerability or risk of arrhythmias in patients. Similarly, genetic polymorphisms of drug-metabolizing enzymes give rise to distinct subgroups within the population that affect specific drug biotransformation reactions. Nonetheless, identification of triggers involved in initiation or maintenance of cardiac arrhythmias remains a major challenge. Herein, we provide an overview of knowledge regarding physiopathology of inherited and acquired cardiac arrhythmias along with a summary of treatments (pharmacologic or non-pharmacologic) used to limit their effect on morbidity and potential mortality. Improved understanding of molecular and cellular aspects of arrhythmogenesis and more epidemiologic studies (for a more accurate portrait of incidence and prevalence) are crucial for development of novel treatments and for management of cardiac arrhythmias and their consequences in patients, as their incidence is increasing worldwide.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Ferdinand Vandry Pavillon, 1050 Av. de la Médecine, Québec City, QC G1V 0A6, Canada.
- Faculty of Pharmacy Ferdinand Vandry Pavillon, 1050 Av. de la Médecine, Québec City, QC G1V 0A6, Canada.
- Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec-Université Laval 2725 Chemin Sainte-Foy, Québec City, QC G1V 4G5, Canada.
ORCID-Profile: John Kingma, Chantale Simard
Zitieren
APA
Kingma, J., Simard, C., & Drolet, B. (2023). Overview of Cardiac Arrhythmias and Treatment Strategies. Pharmaceuticals, 16(6), 844. https://doi.org/10.3390/ph16060844
Vancouver
Kingma J, Simard C, Drolet B. Overview of Cardiac Arrhythmias and Treatment Strategies. Pharmaceuticals. 2023;16(6):844. doi:10.3390/ph16060844
BibTeX
@article{Kingma2023,
author = {Kingma, John and Simard, Chantale and Drolet, Benoît},
title = {Overview of Cardiac Arrhythmias and Treatment Strategies},
journal = {Pharmaceuticals},
year = {2023},
volume = {16},
number = {6},
pages = {844},
doi = {10.3390/ph16060844}
}
EUVIMED